OXFORD IMMUNOTEC GLOBAL LIMITED

Company number 08654254 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£170,236

Balance sheet as at 2023-12-31

View full accounts →

What it does

The principal activity of the Company is that of a holding company on behalf of the Revvity (UK) Holdings Limited group of companies.

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2013-08-16
Employees
0 (2023 accounts)
Registered office
143 Park Drive, Milton, Abingdon, England, OX14 4SE
Postcode
OX14 4SE
Capital
180 GBP
Accounts category
Full
Charges
0 outstanding

Accounts

Last made up to
2024-12-29
Next due by
2026-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-08-14
Next due by
2027-08-28
View filing history →

Nature of business (SIC)

  • 21200 Manufacture of pharmaceutical preparations

Officers 12 current · 9 resigned

Appointed 2024-01-18
Joel GOLDBERG Director
Appointed 2021-03-08
Appointed 2019-11-18
MARK KLAUSNER Director
INVESTOR RELATIONS Appointed 2018-03-01
RETIRED CEO, PRINCIPAL OF APALACHEE VENTURES Appointed 2016-01-29

View all officers and resignations →

Group structure

Controlled by REVVITY (UK) HOLDINGS LIMITED — since 2021-03-07

From persons-with-significant-control filings on the public register.

Contact details

Website
http://www.oxfordimmunotec.com

Previous company names

NameDate changed
OXFORD IMMUNOTEC GLOBAL PLC2021-03-17

Previous registered addresses 1

AddressChanged on
94C INNOVATION DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, OX14 4RZ2014-10-01

The class of 2013

23%

of the 530,510 companies incorporated in 2013 are still active today; 75% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →